ENERCA is a European
network for rare and congenital anaemias. It is a project co-funded by the
European Commission (DG SANCO) through the
Executive Agency for Health and Consumers
(EACH). ENERCA has promoted awareness and knowledge on rare anaemias both for
the public and for health professionals through its website since 2003.
Rare anaemias include
some 90 syndromes, each one rarely encountered in clinical practice, and so are
often undiagnosed or misdiagnosed, and given inappropriate treatment. These
problems are shared with many other rare disorders and there is a close
collaboration of the ENERCA project with the EURopean Organisation for Rare
DISeases (EURORDIS) and Orphanet.
The ENERCA project has
successfully completed two cycles, ENERCA I and II, and the project to be funded
is now labeled ENERCA III. This new version includes added objectives such as:
- The creation of a network of expert
centres for rare anaemias, with the adoption of criteria for such centres
based on those adopted by the Rare Diseases Task Force of DG SANCO.
- The harmonization of diagnostic procedures
and clinical practices through agreed guidelines and standards.
- Education and training of health
professionals and dissemination of information to patients and the public,
through workshops and other activities in addition to the development of the
website.
- Encouraging collaborative research.
Rare anaemias include
the haemoglobin disorders in Europe. In
recognition of the increasing frequency and importance of these disorders they
have been allocated separate workpackages in ENERCA III, one for Thalassaemia
(led by the Thalassaemia International Federation) and one for Sickle Cell
Disease (led by Dr Beatrice Gulbis). To promote
collaborative, multi-centre research, which is paramount in the case of rare
diseases, ENERCA is to collaborate with the ITHANET project and to use the
e-infrastructure to assist researchers in their communications and exchange of
data.